Renzapride
Renzapride is a full serotonin 5-HT4 receptor agonist, partial serotonin 5-HT3 receptor antagonist.
Clinical Uses
As of 2005, it is in late-stage clinical development for the treatment of both constipation-predominant irritable bowel syndrome (IBS-C) and irritable bowel syndrome with alternating stool pattern (IBS-A). It is being devloped by Alizyme of the U.K.
Clinics & treatments
Medic8® Guides
- Cosmetic Surgery
- Cosmetic Dentistry
- Weight Loss Surgery
- Laser Eye Surgery
- Laser Hair Removal
- Health Insurance
- Life Insurance
- Family Health
- Travel Health
- Medical Tourism
- Hair Loss
- Stop Smoking
Health centres
- Allergies
- Alternative Health
- Arthritis
- Asthma
- Blood Disorders
- Bones & Joints
- Bowel & Abdominal Problems
- Cancer
- Chest Problems
- Child Health
- Circulation Problems
- Diabetes
- Diet & Nutrition
- Drug Addiction
- Ear, Nose, & Throat Problems
- Elderly Health
- Eye Problems
- Hair Loss
- Heart Problems
- High Blood Pressure
- Hormone & Endocrine Problems
- Infections
- Infertility
- Liver Problems
- Medications
- Men's Health
- Mental Health
- Nervous System
- Personal & Social Issues
- Pregnancy & Birth
- Preventive Health
- Radiology
- Sexual Health
- Skin Problems
- Sports Medicine
- Surgery
- Travel Health
- Urinary & Kidney Problems
- Vaccination
- Women's Health
